Terms: = Prostate cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Diagnosis
5 results:
1. The expression of YWHAZ and ndrg1 predicts aggressive outcome in human prostate cancer.
Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
[TBL] [Abstract] [Full Text] [Related]
2. Quantitative analysis of BTF3, HINT1, ndrg1 and ODC1 protein over-expression in human prostate cancer tissue.
Symes AJ; Eilertsen M; Millar M; Nariculam J; Freeman A; Notara M; Feneley MR; Patel HR; Masters JR; Ahmed A
PLoS One; 2013; 8(12):e84295. PubMed ID: 24386364
[TBL] [Abstract] [Full Text] [Related]
3. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia upregulates the expression of the ndrg1 gene leading to its overexpression in various human cancers.
Cangul H
BMC Genet; 2004 Sep; 5():27. PubMed ID: 15341671
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis.
Cangul H; Salnikow K; Yee H; Zagzag D; Commes T; Costa M
Cell Biol Toxicol; 2002; 18(2):87-96. PubMed ID: 12046693
[TBL] [Abstract] [Full Text] [Related]
